It may promote acid reflux, also known as GERD, by relaxing the lower esophageal sphincter muscle.
The evidence for antacids is weaker with a benefit of about 10% (NNT=13) while a combination of an antacid and alginic acid (such as Gaviscon) may improve symptoms 60% (NNT=4).
Parkinson's disease | Alzheimer's disease | Centers for Disease Control and Prevention | Huntington's disease | Centers for Disease Control | Bright's disease | Dutch elm disease | disease | Crohn's disease | Chagas disease | sexually transmitted disease | Plague (disease) | Chronic obstructive pulmonary disease | Sexually transmitted disease | Lyme disease | Gaucher's disease | cardiovascular disease | Asbestos Disease Awareness Organization | Alzheimer's Disease | Paget's disease of bone | Motor Neurone Disease Association | Graves' disease | End stage renal disease | chronic obstructive pulmonary disease | Chronic kidney disease | chronic kidney disease | Cardiovascular disease | Batten disease | Tay-Sachs disease | Schilder's disease |